ResearcherInstitute of Cancer ResearchActive in the last 2 years
Kai Tai Derek Yeung
Matched on ORCID iD 0000-0002-5679-9435; OpenAlex author ID A5034154374. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 4
- Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer Centre Experience. Co-author DOI 10.3390/cancers18101597↗
- Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer. Co-author DOI 10.21037/hbsn-2025-550↗
- Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/as9.0000000000000486↗
- Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16020452↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ricky Harminder Bhogal · 4 shared papers, 2024–2026 · strength 1.28
- Paper Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer. DOI 10.21037/hbsn-2025-550↗
- Paper Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Aden… DOI 10.1097/as9.0000000000000486↗
- Paper Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer … DOI 10.3390/cancers18101597↗
- David Cunningham · 3 shared papers, 2024–2026 · strength 0.74
- Paper Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Aden… DOI 10.1097/as9.0000000000000486↗
- Paper Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer … DOI 10.3390/cancers18101597↗
- Paper Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Aden… DOI 10.3390/cancers16020452↗
- Long R. Jiao · 2 shared papers, 2024 · strength 0.51
- Paper Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Aden… DOI 10.1097/as9.0000000000000486↗
- Paper Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Aden… DOI 10.3390/cancers16020452↗
- Katharine L. Aitken · 2 shared papers, 2024–2026 · strength 0.46
- Paper Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer … DOI 10.3390/cancers18101597↗
- Paper Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Aden… DOI 10.3390/cancers16020452↗
- Naureen Starling · 1 shared paper, 2026 · strength 0.24
- Ian Chau · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.